Quinolines (including hydrogenated)

Subclass of:

546 - Organic compounds -- part of the class 532-570 series

546000000 - ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)

546000000 - HETEROCYCLIC CARBON COMPOUNDS CONTAINING A HETERO RING HAVING CHALCOGEN (I.E., OXYGEN, SULFUR, SELENIUM, OR TELLURIUM) OR NITROGEN AS THE ONLY RING HETERO ATOMS (Class 540, subclass 1)

546001000 - Hetero ring is six-membered consisting of one nitrogen and five carbons

546026000 - Polycyclo ring system having the six-membered hetero ring as one of the cyclos

546112000 - Bicyclo ring system having the six-membered hetero ring as one of the cyclos

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application number	Description	Number of patent applications / Date published
546153000	Chalcogen attached directly to the six-membered hetero ring by nonionic bonding	74
546174000	Having -C(=X)-, wherein X is chalcogen, attached indirectly to the quinoline ring system by nonionic bonding	42
546173000	Unsaturated carbocyclic ring attached directly to the quinoline ring system by nonionic bonding (e.g., quinophthalones, etc.)	18
546172000	Acyclic sulfur bonded directly to oxygen and directly or indirectly to the quinoline ring system by nonionic bonding	11
546159000	Nitrogen, other than as nitro or nitroso, attached directly to the six membered hetero ring by nonionic bonding	11
546171000	Nitrogen, other than as nitro or nitroso, attached directly to the carbocyclic ring of the quinoline ring system by nonionic bonding	8
546168000	Having -C(=X)-, wherein X is chalcogen, bonded directly to the quinoline ring system	8
546180000	Halogen or nitro attached directly or indirectly to the quinoline ring system by nonionic bonding	7
546167000	Unsaturated hetero ring attached directly to the quinoline ring system by nonionic bonding	6
546165000	Single bond between 1,2-positions and single bond between 3,4-positions	6
546178000	Chalcogen attached directly to the carbocyclic ring of the quinoline ring system by nonionic bonding	5
20160120858	PHARMACEUTICAL COMPOSITION CONTAINING CLIOQUINOL FOR TREATING AUTISM SPECTRUM DISORDERS - The present invention relates to a pharmaceutical composition for treating autism spectrum disorders, which includes clioquinol or pharmaceutically acceptable salt thereof. In addition, the present invention relates to a food composition for treating autism spectrum disorders, which includes clioquinol or pharmaceutically acceptable salt thereof.	05-05-2016
20090247760	Preparation of Amides from an Acid and Amine for Intermediates in the Synthesis of Morphinans - The present invention is directed to processes for the synthesis of morphinans. In particular, a process for coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl	10-01-2009
20090247761	Preparation of 3,4-Dihydroisoquinolines in the Synthesis of Morphinans - The present invention is directed to processes for the synthesis of morphinans. In particular, a process for coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl	10-01-2009
20130090477	Thiazolylpiperidine Derivatives as Fungicides - Thiazolylpiperidine derivatives of the formula (I),	04-11-2013
20150336866	SYNTHESIS OF DIFLUOROMETHYL ETHERS AND SULFIDES - The synthesis of difluoromethyl ethers and sulfides with a simple, non-ozone-depleting reagent is described. The difluoromethylation of phenols with this reagent occurs at room temperature within minutes with exceptional functional group tolerance. The mild conditions makes possible tandem processes for the conversion of aryl boronic acids, aryl halides and arenes to difluoromethyl ethers. Mechanistic studies support a reaction pathway involving nucleophilic attack of the phenolate to difluorocarbene.	11-26-2015
546181000	Quinolines which are unsubstituted or which are alkyl or alkenyl substituted only, or salt thereof	3
20080262233	SYNTHESIS OF PREFFERED ISOMER FRACTIONS OF N, N-DIETHYLDECAHYDROQUINOLINIUM CATION - The present invention relates to a process for synthesizing trans-N,N-diethyldecahydroquinolinium cation or a mixture of a cis-N,N-diethyldecahydroquinolinium cation and a trans-N,N-diethyldecahydroquinolinium cation.	10-23-2008
20130116438	IRIDIUM COMPLEX AND METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND - An object of the present invention is to provide a novel iridium complex, and to provide a novel catalyst having excellent performances in terms of enantioselectivity, catalytic activity, and the like. Provided is an iridium complex of the following general formula (1):	05-09-2013
20150344431	METHOD FOR PRODUCING PURIFIED AMINE COMPOUND - A method for producing a purified amine compound represented by the formula (1), including: step (A) of reacting a crude form of the amine compound represented by the formula (1) with a hydrogen halide in the presence of water and an organic solvent insoluble in water; step (B) of separating a phase in which a hydrogen halide salt of the amine compound represented by the formula (1) produced in step (A) is dissolved from the other phase(es); step (C) of precipitating the hydrogen halide salt of the amine compound represented by the formula (1) from the phase obtained in step (B) in which the hydrogen halide salt of the amine compound represented by the formula (1) is dissolved; and step (D) of isolating the hydrogen halide salt of the amine compound represented by the formula (1) precipitated in step (C), and reacting the salt with a base.	12-03-2015
546176000	Nitrogen, other than as nitro or nitroso, attached indirectly to the quinoline ring system by nonionic bonding	3
20100324295	PROCESS FOR THE PRODUCTION OF SUBSTITUTED 5-QUINOLYL-OXAZOLES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - The present invention relates a process for the preparation of a compound of the formula:	12-23-2010
20140018541	UMSYMMETRICAL BISAZIDES FOR CHEMOSELECTIVE SEQUENTIAL LIGATION - Unsymmetrical bisazides containing chelating and non-chelating azido groups undergo chemoselective three-component copper(I)-catalyzed azide-alkyne conjugation reactions with two different alkyne molecules. In conjunction with the reactivity gap between aromatic and aliphatic alkynes, a bistriazole molecule can be generated with an excellent regioselectivity by mixing two alkynes and a bisazide in a single reaction container. This method is applicable in aqueous solutions at neutral pH, which may lend utilities in bioconjugation applications.	01-16-2014
20140221658	INHIBITION OF CELL PROLIFERATION - The disclosed modulators of Rb:Raf-1 interactions are potent, selective disruptors of Rb:Raf-1 binding, with IC	08-07-2014

Entries
Document	Title	Date
20080214822	Process For the Preparation of a Leukotriene Antagonist - The present invention relates to a novel process for the preparation of montelukast sodium, a compound of Formula (1b) and precursors thereof. The invention further concerns the free acid of this compound in crystalline form, obtainable for the first time by the new process.	09-04-2008
20090054652	Cyanine Compound and Optical Recording Material - A cyanine compound is represented by formula (I):	02-26-2009
20100016597	Method for producing pulverized organic compound particle - Disclosed is a method for producing pulverized particles of a crystalline organic compound which is poorly water-soluble. Also disclosed is a pulverized organic compound particle produced by such a method. Specifically disclosed is a method for producing a poor water solubility organic compound particle for medical use, which is characterized in that a poor water solubility organic compound for medical use is mixed with a physiologically acceptable salt and a physiologically acceptable polyol, and subjected to wet milling. Also specifically disclosed is a poor water solubility organic compound particle for medical use, which is produced by such a production method.	01-21-2010
20100280248	NOVEL COMPOUNDS THAT ARE USEFUL FOR IMPROVING PHARMACOKINETICS - Novel compounds of formula 1	11-04-2010
20100305326	Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage - Disclosed herein are methods related to drug development. The methods typically include steps whereby two chemical fragments are identified as binding to a target protein and subsequently the two chemical fragments are joined to create a new chemical entity that binds to the target protein.	12-02-2010
20110282065	SOLID SUPPORTED GOLD NANOPARTICLES, METHODS OF USE THEREOF, AND METHODS FOR MAKING SAME - Solid-supported gold nanoparticles for use as a catalyst for the synthesis of quinolines from anilines and aldehydes using oxygen as an oxidant are provided. Also provided are a method for the preparation of SiO	11-17-2011
20120323011	PROCESS AND INTERMEDIATE COMPOUNDS USEFUL IN THE PREPARATION OF STATINS - There is provides a process for the preparation of a compound of formula (7): wherein R is an optionally substituted hydrocarbyl group or an optionally substituted heterocyclic group; provides that R is not a compound of Formula (a): wherein R	12-20-2012